|Articles|September 15, 2002
- BioPharm International-09-01-2002
- Volume 15
- Issue 9
If a Tree Fell in the Forest
Author(s)Jim Miller
by Jim Miller, Bio/Pharmaceutical Outsourcing Report If a CRO or contract manufacturer was outperforming others in the industry, would anybody notice?
Advertisement
Articles in this issue
about 23 years ago
Reexamining the Set It and Forget It Approachabout 23 years ago
Security in the Corporate Homelandabout 23 years ago
Integrating New Technology into Blood Plasma Fractionationabout 23 years ago
Attack Mounts on Pharmaceutical PricesNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Strategic Shifts for Speed, Resilience, and Long-Term Sustainability in Biomanufacturing
2
Why Data Quality, Not Regulation, Is the True Barrier to AI in Biologics
3
How Is AI Transforming Biomanufacturing and Biopharma Workforce Training?
4
RNAnalytics CPHI Interview, Part Two: Nanoparticle Case Studies and Response to US mRNA Pullback
5
